How much funding has Aquinnah Pharmaceuticals Inc. raised?

Aquinnah Pharmaceuticals Inc. has raised $16.7M in total funding, most recently a grant round.

When was Aquinnah Pharmaceuticals Inc. founded?

Aquinnah Pharmaceuticals Inc. was founded in 2015.

Where is Aquinnah Pharmaceuticals Inc. headquartered?

Aquinnah Pharmaceuticals Inc. is headquartered in Newton, Massachusetts, United States.

What industry is Aquinnah Pharmaceuticals Inc. in?

Aquinnah Pharmaceuticals Inc. operates in Biotech, Healthcare.

How many employees does Aquinnah Pharmaceuticals Inc. have?

Aquinnah Pharmaceuticals Inc. has 1-10 employees.

Aquinnah Pharmaceuticals Inc.

Aquinnah Pharmaceuticals

Newton, United States · Founded 2015 · $16.7M raised

Biotech

Healthcare

Headquarters: Newton, Massachusetts
Employees: 1–10
Founded: 2015
Business Model: B2B

Website: aquinnahpharma.com
Total Funding: $16.7M
Last Round: $11.0M GrantJan 2026

About

Aquinnah Pharmaceuticals is a clinical-stage biotechnology company developing oral small molecule therapeutics that modulate pathological biomolecular condensates — particularly stress granules — implicated in ALS, Alzheimer's disease, and other neurodegenerative disorders. Founded by Dr. Benjamin Wolozin, the company has received investment from Pfizer, AbbVie, and Takeda, alongside NIH grants and a collaboration with Roche to advance ALS therapies.

Summary

Aquinnah Pharmaceuticals Inc. is a Biotech company based in Newton, United States, founded in 2015. It has raised $16.7M in total, most recently a $11.0M Grant round in Jan 2026.